DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,033,000 | -56.3% | 150,459 | -19.0% | 0.00% | -66.7% |
| Q2 2021 | $6,936,000 | +52.3% | 185,857 | +4.3% | 0.00% | +50.0% |
| Q1 2021 | $4,555,000 | +44.8% | 178,157 | +24.8% | 0.00% | +100.0% |
| Q4 2020 | $3,145,000 | +22.5% | 142,759 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,568,000 | -40.8% | 142,759 | -16.3% | 0.00% | -66.7% |
| Q2 2020 | $4,335,000 | +68.3% | 170,650 | +21.8% | 0.00% | +50.0% |
| Q1 2020 | $2,575,000 | -18.1% | 140,150 | -1.8% | 0.00% | 0.0% |
| Q4 2019 | $3,143,000 | +233.7% | 142,650 | +117.5% | 0.00% | +100.0% |
| Q3 2019 | $942,000 | -8.8% | 65,600 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,033,000 | +21.8% | 65,600 | +13.3% | 0.00% | 0.0% |
| Q1 2019 | $848,000 | +105.8% | 57,900 | +50.4% | 0.00% | – |
| Q4 2018 | $412,000 | -9.6% | 38,500 | +28.8% | 0.00% | – |
| Q3 2018 | $456,000 | +196.1% | 29,900 | +137.3% | 0.00% | – |
| Q2 2018 | $154,000 | +55.6% | 12,600 | +207.3% | 0.00% | – |
| Q1 2015 | $99,000 | +371.4% | 4,100 | +215.4% | 0.00% | – |
| Q4 2014 | $21,000 | -36.4% | 1,300 | -50.0% | 0.00% | – |
| Q3 2014 | $33,000 | -44.1% | 2,600 | 0.0% | 0.00% | – |
| Q2 2014 | $59,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |